Abadie's exit from CHMP: EMA rejected French agency salary request
This article was originally published in SRA
Executive Summary
Eric Abadie's resignation as chairman of the European Medicines Agency's key human drugs evaluation committee, the CHMP, came after the EMA rejected a request from the French medicines regulator, Afssaps, to pay Dr Abadie a salary1,2. CHMP members do not traditionally receive a salary.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.